The CRAFFT is a (updated version of a) behavioral health screening tool for use with children ages and is recommended by the American Academy of . The CRAFFT Screening Interview. The CRAFFT is a behavioral health screening tool for use with children under the age of 21 and is recommended by the. CRAFFT is a screening tool for adolescent substance use that has been validated in outpatient general medical settings. This is the first study to examine its use.
|Published (Last):||23 October 2008|
|PDF File Size:||11.15 Mb|
|ePub File Size:||17.89 Mb|
|Price:||Free* [*Free Regsitration Required]|
National Survey Results on Drug Use, The CAGE questions, which are widely used in medical settings, are a good example of this type of brief screen. There were a total of 59 abuse diagnoses; 16 were for alcohol alone, 30 for other drugs alone, and 13 for both alcohol and other drugs.
The CRAFFT test has acceptable sensitivity and specificity for identifying all screening categories and among all demographic subgroups. This study demonstrates that the brief CRAFFT test has good validity for identifying substance-related problems and disorders in adolescent medical patients. Sign in to save your search Sign in to crafdt personal account. Animal testing Archival research Behavior epigenetics Case study Content analysis Experiments Human subject research Interviews Neuroimaging Observation Psychophysics Qualitative research Quantitative research Self-report inventory Statistical surveys.
The extent to which some participants may have underreported and others scdeening their use of substances is unknown. Prevalence rates among adolescent patients seen in other clinics, family practices, or general pediatric practices may be different.
Sign in to make a comment Sign ctafft to your personal account. Reliability and validity of pastmonth use frequency items as opening questions for the updated CRAFFT adolescent substance use screening system.
During the sfreening recruitment period, providers invited adolescent patients to participate in the study. All research assistants read the ADI manual, watched model interviews, practiced on volunteers, and were videotaped conducting practice interviews. A receiver operating characteristic area of 1 upper-left corner of the graph theoretically indicates that the test is always correct, and an area of 0.
CRAFFT as a Substance Use Screening Instrument for Adolescent Psychiatry Admissions.
We transformed participant age into a dichotomous variable ie, younger youth and older youth based on the sample median to preserve adequate cell size for analyses. Preventive services in a health maintenance organization.
There are limitations to the generalizability of our findings regarding diagnostic classifications. Toil were almost equally distributed across years of age; This page was last edited on 3 Octoberat Participants with both abuse and dependence diagnoses eg, cannabis abuse and alcohol dependence were classified as having dependence. Receiver operating characteristic curves are presented in Figure 2.
The findings on prevalence may be further limited, in that the study sample, although generally reflective of the clinic population at large, was not selected randomly. Am J Obstet Gynecol. We compared CRAFFT scores with other measures of yool use, including urine drug screens and the diagnosis of a substance use disorder at discharge. Sign in to customize your interests Sign in to your personal account.
CRAFFT Screening Tool | Patient Centered Primary Care Institute
Clinical and Experimental Research27 1: They may require staff time for administration or scoring. Validity was not significantly affected by age, sex, or race.
Substance abuse has been linked to both mental and physical health problems, making settings where adolescents receive medical care ideal places for screening and early intervention. However, the relative risk of a false-positive test eg, additional interview is low compared with that of a false-negative ie, missed diagnosis and opportunity for early intervention.
A pilot study among adolescent patients who had used alcohol and other drugs found that CRAFFT had promising concurrent validity compared with a more lengthy scale. Simple yes or no questions that lend themselves to mnemonic acronyms are ideal. Arch Pediatr Adolesc Med. Sensitivity, specificity, and positive and negative predictive values of a CRAFFT score of 2 or higher for identifying each of the 3 screening categories are presented in Table 2.
J Am Dent Assoc. Get free access to newly published articles Create a personal account or sign in to: We plotted receiver operating characteristic curves to determine the optimal cut point for the CRAFFT test ie, total score with the highest product of sensitivity and specificity for identifying 3 screening categories: However, we cannot assess to what degree they followed this instruction; provider selection bias, resulting in higher than actual prevalence estimates for disorders, remains a possibility.
The ideal instrument for screening adolescents must be developmentally appropriate, valid and reliable, and practical for use in busy medical offices. Almost 1 in 6 Journal of studies on alcohol.
The research assistant told participants that the purpose of the study was to assess the value of screening questions on use of alcohol and other drugs and that we would keep their answers confidential. Archivos argentinos de pediatria.
This study was conducted in toil single urban hospital-based adolescent clinic.
Languages Simple English Edit links. Of cragft 29 drug dependence diagnoses, 27 were related to cannabis use, and 2 were related to use of 3,4-methylenedioxymethamphetamine MDMA or “ecstasy”.
Adolescent alcohol and drug use and health. New approaches, such as office-based interventions, must be developed to adequately meet the need for treatment. Create a free personal account to access your subscriptions, sign up for alerts, and more. This study provides good supportive evidence for the validity of the CRAFFT test as a substance abuse screening device for use among a general toool of adolescent clinic patients.